2nd Quarter - Report
DENNY MILLER ASSOCIATES for CELL THERAPEUTICS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
Medical/Disease Research/Clinical Labs MED
S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JUDSON GREIF | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.